GlassScriptPhysician profile
Huan N Vu
NPI 1558328773
$344.64
in general payments reported to CMS, 2019-2025
16 companies · $56.93 in 2025
The $56.93 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $12.79 · 2022: $67.99 · 2023: $40.78 · 2025: $56.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $97.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $97.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $67.27 | 2022-2023 | Zynrelef |
| Csl Behring | $55.98 | 2019-2022 | |
| Amgen INC. | $23.93 | 2019 | |
| Atricure, INC. | $23.29 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Inari Medical, INC. | $18.97 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Acell, INC. | $18.49 | 2019 | |
| Integra Lifesciences Corporation | $18.04 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Rigel Pharmaceuticals, INC. | $17.52 | 2019 | |
| Ethicon US, LLC | $15.60 | 2025 | Echelon Endopath, Harmonic |
| Tersera Therapeutics LLC | $14.80 | 2019 | |
| Allergan, INC. | $12.94 | 2019 | |
| Kci USA, INC. | $12.79 | 2020 | |
| Incyte Corporation | $11.76 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.50 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $10.92 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Huan Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.